Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double‐blind, randomized trial

AIMS: To investigate the efficacy and safety of insulin degludec/liraglutide (IDegLira) compared with 50 U insulin degludec (degludec) or less in Japanese individuals with type 2 diabetes (T2D). MATERIALS AND METHODS: In this 26‐week, double‐blind, multicentre, treat‐to‐target trial, Japanese indivi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Obes Metab
Glavni autori: Watada, Hirotaka, Kaneko, Shizuka, Komatsu, Mitsuhisa, Agner, Bue Ross, Nishida, Tomoyuki, Ranthe, Mattis, Nakamura, Jiro
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2019
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900157/
https://ncbi.nlm.nih.gov/pubmed/31423685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13859
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items